PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of springeropenLink to Publisher's site
Journal of Molecular Medicine (Berlin, Germany)
 
J Mol Med (Berl). 2013; 91(9): 1081–1093.
Published online 2013 June 25. doi:  10.1007/s00109-013-1063-8
PMCID: PMC3761091

Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus

Abstract

Abstract

Microvascular ischemia and infections are associated with the development of chronic rejection following lung transplantation. The von Hippel–Lindau protein (VHL) controls protein levels of hypoxia-inducible factors (HIFs), regulates vascular repair, and improves tissue perfusion. Here, we studied the role of VHL in microvascular repair by orthotopically transplanting tracheas into mice with VHL haplodeficiency in Tie2 lineage cells. We showed that VHL haplodeficiency prolonged airway microvascular perfusion and promoted tissue blood flow through the production of the angiogenic factors, SDF-1 and angiopoietin 1. VHL-haplodeficient pulmonary endothelial cells exhibited increased angiogenic activity, resistance to serum deprivation-induced cell death, and enhanced microvascular repair. By contrast, in recipient mice with HIF-1α deficiency in Tie2 lineage cells, microvascular repair was significantly diminished and suggested that recipient-derived HIF-1α normally participates in the repair of alloimmune-mediated microvascular damage. To evaluate the translational impact of our findings, we compared VHL-haplodeficient mice with wild-type controls using a model of Aspergillus airway infection. In 83 % of the VHL-haplodeficient recipients, Aspergillus fumigatus was noninvasive in contrast to 75 % of wild-type mice in which the mold was deeply invasive. Our study demonstrated that stabilization of HIF-1α in angiogenic cells, through Tie2 cell VHL haplodeficiency, promoted airway microvascular regeneration and vascular normalization and thereby minimized tissue ischemia and hypoxia. By also mitigating the virulence of A. fumigatus, a common pathogen and itself a risk factor for the development of lung transplant rejection, the selective enhancement of HIF-1α expression has the prospect of offering several novel therapeutic effects to transplant recipients.

Key message

  • Microvascular loss and prolonged ischemia occurs with acute rejection.
  • Von Hippel-Lindau (VHL) protein controls hypoxia inducible factors (HIFs).
  • In tracheal allografts, VHL haplodeficient Tie2 cells promote neovascularization.
  • Reduced transplant ischemia limits Aspergillus invasion.

Electronic supplementary material

The online version of this article (doi:10.1007/s00109-013-1063-8) contains supplementary material, which is available to authorized users.

Keywords: HIF-1α, Aspergillus fumigatus, VHL, Orthotopic tracheal transplant, Obliterative bronchiolitis, Chronic lung transplant rejection, Microvascular perfusion

Introduction

The main obstacle for long-term survival of lung transplant recipients is chronic rejection, histologically manifested as obliterative bronchiolitis (OB). Yet, the mechanisms by which OB develops remain poorly understood [1]. Recent autopsy studies have shown that airway microcirculatory dysfunction and ensuing small airway ischemia precede the onset of OB [2, 3]. Infections after lung transplantation also contribute to the development of OB [4]. Among these pathogens, infection with Aspergillus fumigatus results in a variety of diseases including: Aspergillus colonization, which contributes to OB, airway anastomotic infections, and invasive pulmonary aspergillosis [46]. For lung transplant recipients, infection with A. fumigatus represents a major cause of morbidity, with mortality rates as high as 82 % [58]. In addition to the pathogen’s putative role in chronic rejection, ischemic areas also may provide a substrate for fungal growth because A. fumigatus derives its nourishment from decaying organic matter. Thus, microvascular injury may be a central factor for the development of OB by promoting chronic allograft rejection and by fostering infections with OB-inducing microorganisms such as A. fumigatus.

In a murine orthotopic tracheal transplantation (OTT) model, we found that airway microvascular injury with associated tissue ischemia and hypoxia is apparent during acute rejection, which is followed by vascular regeneration and remodeling [9]. We further demonstrated that enhancing microvascular integrity during the acute phase of rejection preserved the airway architecture and attenuated chronic rejection [10]. How damaged airway microvasculature is repaired and regenerated during rejection episodes is incompletely understood. Additionally, it is not known whether enhanced airway microvascular regeneration can be achieved through augmenting the functional capacity of recipient-derived angiogenic cells and what role modulating microvascular ischemia may play in pathogen virulence.

The VHL gene encodes a multifunctional protein, pVHL, the substrate-binding subunit of an E3 ubiquitin ligase, which plays an important role in oxygen-sensing pathways by regulating the degradation of hypoxia-inducible factor (HIF)-1α subunit [11]. In the presence of oxygen, two proline residues of HIF-1α are hydroxylated by the prolyl hydroxylase PHD2, facilitating pVHL complex binding, to direct proteasomal degradation of HIF-1α. In hypoxic conditions, PHD2 is inactive and HIF-1α is stabilized. HIF-1α then dimerizes with the β subunit, translocates to the nucleus, and induces gene transcription through binding to hypoxia response elements on enhancers of the oxygen-sensitive genes [12].

In the OTT model, damaged airway microvasculature is repaired by recipient-derived Tie2-expressing cells, comprised of three major subpopulations: cells of endothelial lineage, Tie2-expressing monocytes (TEM) of myeloid origin, and pericyte precursors of mesenchymal derivation [10]. HIF-1α stabilization by adenosine-mediated signaling increases cellular adaptation to ischemic conditions [13]. In a mouse hind limb ischemia model, HIF-1α gene therapy increased homing of bone marrow-derived angiogenic cells (BMDACs); combined with the induction of HIF-1α in BMDACs, which promoted BMDAC survival in ischemic areas, this approach synergistically enhanced revascularization [14, 15]. Endothelial cell (EC) PHD2 haplodeficiency normalizes tumor microvasculature structure and diminishes metastasis [16]. Together these studies suggest that increasing HIF expression in angiogenic cells promotes vascular repair and tissue normoxia.

We subsequently hypothesized that increasing HIF-1α expression in Tie2-expressing cells would enhance airway microvascular regeneration. To achieve this, we specifically knocked down VHL in Tie2 lineage cells and examined how VHL haplodeficiency altered airway microvascular repair. We then evaluated the translational impact of increased tissue vascularization, using a model of Aspergillus tracheal infection. The main objective of this study was to determine whether airway microvascular repair and regeneration could be enhanced through increased expression of HIF-1α in recipient-derived angiogenic cells and if this effect would modify the A. fumigatus host–pathogen interaction.

Materials and methods

Mice

All animal procedures were approved by Stanford’s Administrative Panel on Laboratory Animal Care and/or the VA Palo Alto Institutional Animal Care and Utilization Committee. In addition, the Stanford University Applied Panel on Biosafety (protocol number 1007-MN0312) approved all microbiological experiments performed in this study. All mice including C57BL/6J (B6; H-2b), Balb/c (H-2d), C; 129S-Vhltm1Jae/J, B6.Cg-Tg (Tek-cre)12Flv/J; and B6.129-Hif1atm3Rsjo/J were purchased from the Jackson Laboratory.

To create VHL haplodeficiency in Tie2 lineage cells, mice with loxP sites on both sides of exon 1 of the VHL gene (VHLloxP/loxP) were crossed with mice expressing Cre under promoter Tie2 (Tie2Cre mice). Tie2Cre(−)VHL(fl/+) were used as control and Tie2Cre(+)VHL(fl/+) mice as Tie2 lineage VHL haplodeficiency. For HIf-1α knockout in Tie2 lineage cells, mice with HIF-1α exon 2 floxed (HIF-1αloxP/loxP) were also crossed with Tie2Cre mice. Tie2Cre(−)HIF1α(fl/fl) mice were used as control and Tie2Cre(+)HIF1α(fl/fl) as Tie2 lineage HIF-1α knockout. Those mice were used as transplant recipients.

Tracheal transplantation

Balb/c mice were used as donors. Mice with transgenes as described above were used as recipients. Basic surgical procedures of tracheal transplantation were carried out as previously described [10]. Briefly, both donor and recipient mice were anesthetized with 50 mg/kg ketamine and 10 mg/kg xylazine. Five- to seven-ring tracheal segments were removed from donor mice that were matched for recipient age and sex. The donor tracheas were stored in PBS on ice before transplantation. A short incision was made in the midline of the neck region of the recipient. The strap muscles were then bluntly divided and pulled aside by a 3-0 suture, which allowed clear exposure of the laryngotracheal complex. After the recipient trachea was transected, donor trachea was sewn in with 10-0 nylon sutures, and the skin was closed with 5-0 silk sutures.

A. fumigatus airway infection model

A. fumigatus, 10AF (ATCC 90240), was used for all infections. Cultures were revived from long-term storage at −80 °C by growth at 37 °C on potato dextrose agar. Conidia were harvested by washing the surface of the agar plate with 0.05 % Tween 80 in saline (vol/vol). Viability was assessed by quantitative plating of serial dilutions of the conidia onto Sabouraud dextrose agar plates. These were incubated for 48 h at 37 °C and the number of colonies counted. The suspension was then diluted to a concentration of 3–4 × 108 conidia per ml. Prior to infection, conidia were centrifuged (5,000×g for 5 min) and then washed twice with 1× PBS after centrifugation to remove excess Tween. Inoculation occurred via intratracheal injection (29-gauge insulin syringe), in which a 40-μl conidial solution was injected to two tracheal rings rostral to the cephalad anastomosis. After inoculation, animals were administered triamcinolone acetonide (40 mg/kg) subcutaneously. At day 2 after infection, all surviving mice were euthanatized using CO2 asphyxia.

Tissue preparation for perfusion studies and immunohistochemistry

For whole-mount tracheal microvascular analysis, mice were injected with 100 μl of FITC-conjugated tomato lectin (Vector Laboratories) at a concentration of 1 mg/ml. After 5 min of circulation, mice were perfused with 1 % paraformaldehyde (PFA) diluted in PBS for about 2 min until the outflow of the solution turned clear. The tracheas were then harvested, put in 1 % PFA for 1 h at 4 °C, and washed three times with PBS. Whole tracheas were mounted on glass slides in Vectashield H-1200 mounting medium (Vector Laboratories). Blood perfusion unit measurement was carried out as described [17]. For assessment of the percentage of the perfused area, we examined the whole tracheal allograft (every cartilaginous and intercartilaginous region), each perfused area received a score of 1 and each non-perfused area received a score of 0. The percentage was then calculated as follows: total score / total regions examined. Frozen sections were used for other immunohistochemistry analysis. Trachea samples were snap-frozen in optimal cutting temperature (OCT) solution (Sakura Finetek) after harvest, and OCT-embedded samples were stored at −80 °C. Eight-micrometer sections were used for immunofluorescence staining. Anti-CD31 (1:200; BD Pharmingen) antibody was used to stain endothelial cells; anti-desmin (1:200; Millipore) antibody was used to stain pericytes; and anti-CD4 (1:200) and anti-CD8 (1:200; BD Pharmingen) were used to stain CD4+ and CD8+ T cells, respectively. Photomicrographs were taken with a Zeiss LSM 510 laser scanning confocal microscope with Zeiss LSM Image Browser software.

Lung EC isolation and culture, Matrigel assay, scratch assay, and cell death assay

Mouse endothelial cell isolation

Dynabeads®Sheep (1 × 107) were coated with anti-rat IgG (Invitrogen, cat. 110.35) then mixed with 1.5 μg rat anti-mouse monoclonal CD31 IgG (BD Pharmingen). The beads and antibody were incubated at 2–8 °C overnight. Mouse lung tissues were minced into 1–2 mm pieces and then digested by adding 10 ml of 1 mg/ml collagenase (Sigma) at 37 °C for 1 h. The cells were filtered through sterile 70 μm nylon mesh and washed twice with 1× PBS. Coated Dynabeads® were added to cells and incubated for 30 min at 4 °C to allow binding to cells. The cells were washed in PBS and bead-bound cells were collected using a magnet and this step was repeated four times. Bead-bound cells were resuspended in DMEM with 20 % FBS.

Matrigel assay

Matrigel (Trevigen BME) was thawed on ice overnight and dispersed on 96-well plates (55 μl per plate) and allowed to polymerize for 30 min at 37 °C. Lung ECs were seeded on the Matrigel at the density of 5,000 cells per well. Cells were incubated at 37 °C with 5 % CO2, and images were taken 6 h later. ImageJ software was used to determine total cellular cord length.

Scratch assay

Lung ECs (6 × 104) were seeded on an Easy Slide (Millipore) until the formation of a confluent monolayer. Cells were then starved in a serum-free medium for 12 h. Pipette tip (size of 200 μl) was used to scratch a straight line across the middle of the cell monolayer. Cell debris was washed off and cells with gap were incubated with 0.2 % serum basal medium. Images were taken immediately after scratch and the same images of the same fields were obtained 6 h later. The rate of cell migration was calculated as the average percent wound closure from at least three independent experiments using ImageJ software. In brief, images were first converted to binary then threshold was adjusted and cell-covered area was highlighted over background. Percentage of cell-covered area was then calculated and denoted as percent wound closure. Serum deprivation-induced cell death was assessed by trypan blue exclusion assay. Endothelial cells were seeded in 24-well plates and cultured in the serum-free medium for 6 h. Cell death was then assessed by trypan blue staining.

Hypoxia assessment, blood perfusion measurement, and vascular leakage study

Airway hypoxia was assessed by using HypoxiprobeTM-1, following manufacturer’s protocol. Briefly, HypoxiprobeTM-1 solution was injected at a dose of 60 mg/kg through peritoneum, and trachea was harvested and frozen in OCT 30 min later. After sectioning, anti-pimonidazole antibody was used to detect pimonidazole adducts which indicates tissue hypoxia. Blood perfusion measurement was carried out as we described [17]. Vascular leakage was analyzed after intravenous injection of 100 μl of cy3-conjugated microsphere (#R50) and 100 μl FITC-lectin at a concentration of 1 mg/ml. Ten minutes later, mouse was perfused with 1 % PFA in PBS. Trachea was then harvested for whole-mount examination under confocal microscopy. The intensity of extravasated microsphere was calculated as described [18].

Quantitative real time RT-PCR

Tracheal samples were first incubated in RNAlater solution (Invitrogen) overnight at 4 °C. Total RNA was then isolated using the QIAGEN Shredder and RNeasy Mini Kit (QIAGEN) following the manufacturer’s protocol. Total RNA (1 μg) was reverse transcribed with Moloney murine leukemia virus reverse transcriptase (Invitrogen) and 5 μM random hexamer primers according to the manufacturer’s instructions. Two microliters of one to ten diluted reverse transcription reactions was added to quantitative real time-PCR with 5 μl of 2× SYBR Green Master Mix (Applied Biosystems) and 100 nM forward and reverse primers specific for the genes of interest in a total volume of 10 μl. Detection was carried out with the ABI Prism 7700 sequence detector (Applied Biosystems). SDS analysis software (Applied Biosystems) was used to analyze the data. 18S mRNA expression was used to normalize gene expression for sample-to-sample variation in input and reverse transcription efficiency. The 2–ΔΔCt method was used to calculate fold changes. All primers used are shown in Supplemental Table 1.

Tissue preparation and evaluation for fungal infection

All tracheal samples were placed in paraffin blocks and cut longitudinally or transversely in 5 μm sections through the entire tracheal segment. Grocott’s methenamine silver (GMS) stain was used for each of these sections (Histotech laboratories). The most severe section was scored for each tracheal sample. Fungal infection was defined by the presence of hyphal elements on GMS stain in the tracheal segment. The degree of fungal burden was scored as follows: 0, no fungal elements, 1 (minimal), fungal hyphae in less than 25 % of the luminal area, 2 (mild) hyphae occluding 25 to 49 % of the luminal area, 3 (moderate) hyphae 50 to 74 % of luminal area, and 4 (severe) greater than 75 % occlusion of the luminal area (Supplementary Fig. 3a). The depth of fungal invasion was graded: 1 (minimal), invasion of the epithelial layer; 2 (mild), invasion of the subepithelial layer; and 3 (moderate), invasion to the depth of the cartilaginous tracheal ring (Supplementary Fig. 3b).

Statistics

Statistical analysis was performed using two-tailed Student’s t test, with a significance level of p < 0.05. Semiquantitative differences in fungal burden and depth of invasion were evaluated by a nonparametric Kruskal–Wallis test.

Results

Tie2+ cell VHL haplodeficiency prolongs airway microvascular perfusion and diminishes tissue hypoxia

The airway microcirculation is easily studied in major histocompatibility complex-mismatched orthotopic tracheal transplants; these are functional allografts through which the mouse breathes. This model system faithfully replicates lymphocytic bronchitis, a large airway precursor of chronic rejection (the bronchiolitis obliterans syndrome) [19]. We previously showed that following alloimmune-induced airway microvascular injury and tissue hypoxia, recipient-derived Tie2-expressing cells are recruited to donor trachea and participate in vascular regeneration [10]. Upregulation of HIF-1α promotes vascular reparative capacity of angiogenic cells [14, 15]. Because VHL negatively regulates HIF-1α protein levels, we hypothesized that downregulation of VHL would promote vascular reparative capacity of Tie2-expressing cells through upregulation of HIF-1α protein. To examine the role of VHL expressed in Tie2+ cells in airway microvascular repair, we conditionally knocked down VHL in Tie2 lineage cells to establish heterozygosity, as homozygous knockout results in embryonic lethality [20]. One allele VHL knockdown has been shown to efficiently decrease VHL protein expression in ECs [21]. Consistent with earlier findings [22, 23], VHL-haplodeficient lung ECs from Tie2Cre(+)VHL(fl/+) mice expressed higher levels of HIF-1α than ECs from Tie2Cre(−)VHL(fl/+) mice (Supplementary Fig. 1). Tie2Cre(−)VHL(fl/+) recipients lost microvascular perfusion in tracheal transplants at day 14 posttransplantation and partial revascularization occurred by day 28, as determined by confocal fluorescence microscopy after intravenous injection of FITC-lectin (Fig. 1a); early loss of perfusion is due to alloimmune rejection and revascularization occurs because of recipient-derived revascularization [10]. In contrast, tracheas transplanted into VHL-haplodeficient recipients showed significantly prolonged perfusion to day 18 posttransplantation and improved revascularization at day 28 (area perfused ~40 vs. ~20 %) (Fig. 1b). Laser Doppler flowmetry (LDF) is another method of examining microvascular perfusion, providing a dynamic measurement of blood flow [17]. We demonstrated that microvascular perfusion of tracheas transplanted into VHL-haplodeficient mice was significantly higher than control mice from day 12 to day 28 following transplantation (Fig. 1c). Using pimonidazole staining to measure tissue hypoxia, we observed decreased tissue hypoxia in tracheas transplanted into VHL-haplodeficient recipients at both day 16 and day 28 posttransplantation (Fig. 1d). As Cre expression in this Tie2-Cre strain may affect 25 % of bone marrow cells [24], we also evaluated the possibility that observed differences in airway perfusion were caused by diminished VHL expression in cells of hematopoietic origin participating in the alloimmune response. As CD4+ and CD8+ T lymphocytes have been previously demonstrated to mediate vascular injury [25], we examined infiltration of these cells in the tracheal allograft of VHL-haplodeficient and control animals. No significant differences were observed in the infiltration of CD4+ or CD8+ T cells in the donor tracheas (Supplementary Fig. 2a). Moreover, no significant differences were observed in mRNA expression levels of common pro-inflammatory chemokines (CXCL9, CXCL10, CXCL11, CCL5, MCP-1, and IFN-γ) (Supplementary Fig. 2b). Together these data suggest that the prolonged microvascular perfusion of tracheal transplants in Tie2Cre(+)VHL(fl/+) recipients likely resulted from accelerated vascular repair by VHL-haplodeficient Tie2+ cells.

Fig. 1
Recipient Tie2+ cell VHL haplodeficiency prolongs airway microvascular perfusion and diminishes tissue hypoxia. a Confocal microscopic FITC-lectin perfusion images showing microvascular perfusion of tracheas transplanted into control recipients with normal ...

VHL-haplodeficient lung endothelial cells exhibit increased angiogenic activity and enhanced resistance to serum starvation-induced cell death

BMDACs with increased HIF-1α expression survive longer in ischemic tissue and promote vascular repair in an ischemic hind limb model [14, 15]. We hypothesized that increasing HIF-1α expression through VHL knockdown would increase angiogenic potency of Tie2+ cells displaying endothelial lineage. Lung ECs were isolated and cultured for experiments between passages 2 and 5. We first examined the effect of VHL loss on EC migration, an essential process for angiogenesis. Scratch assays showed that migration was markedly increased in VHL-haplodeficient ECs when cultured in media containing either 0.5 or 5 % FBS (Fig. 2a, b). EC culture in Matrigel with media containing either 0.5 or 5 % FBS revealed that VHL-haplodeficient cells exhibit significantly increased cord formation (Fig. 2c, d). As the capacity of EC survival in hypoxic tissue is essential for neoangiogenesis and vascular repair, we then evaluated the survival of VHL-haplodeficient ECs in serum deprivation studies. Using a trypan blue assay to assess cell death, we show that VHL-haplodeficient ECs were more resistant to serum deprivation-induced cell death (Fig. 2e). From these experiments, we conclude that VHL-haplodeficiency promoted angiogenesis by increasing EC survival, migration, and cord formation.

Fig. 2
VHL-haplodeficient lung endothelial cells exhibit enhanced angiogenic activity and increased resistance to serum deprivation-induced cell death. a Migration of wild type (WT) and VHL-haplodeficient (VHL+/−) lung EC was assessed by scratch wound ...

VHL haplodeficiency increases angiogenic factor expression in ischemic airways

Expression of angiogenic growth factors and cytokines are closely associated with recruitment of circulating angiogenic cells and are essential for neovascularization. Based on the kinetics of microvascular perfusion of tracheas transplanted into recipients with different levels of VHL expression, mRNA was isolated from day 18 airway transplants, and expression of angiogenic factors, cytokines, and angiogenesis associated receptors was analyzed by quantitative RT-PCR. Expression of HIF-1α, SDF-1, and ANGPT1 was significantly increased in airways transplanted into VHL-haplodeficient recipients, but no significant differences in expression of ANPGT2, VEGF, or PLGF were observed (Fig. 3a). We then examined receptors commonly expressed on reparative ECs. Expression level of Tie2 is significantly higher in tracheas transplanted into VHL-haplodeficient recipients; other receptors such as CXCR4 and VEGFR2 were not significantly different between grafts transplanted into control and VHL-haplodeficient recipients (Fig. 3b). These data suggest that VHL knockdown in recipient Tie2 lineage cells promoted donor vascular repair by increasing the specific expression of angiogenic factors and recruitment (or survival) of vascular reparative cells.

Fig. 3
Analysis of angiogenic cytokines and cognate receptors. a Real time RT-PCR analysis of angiogenic cytokines of day 18 airways transplanted into WT control or VHL-haplodeficient recipients. b Analysis of angiogenesis-related receptors of day 18 airway ...

VHL haplodeficiency improves microvascular function and maturation

Tissue perfusion is determined not only by vessel density, but also by the structural status of the investing microvasculature. Leakiness of microvessels results in extravasated plasma, increased interstitial pressure, and compromised perfusion. Tumor vessels formed by PHD2-deficient ECs are more normalized compared with those formed by wild-type (WT) ECs [16]. To evaluate microvascular permeability in VHL-haplodeficient ECs compared with controls, we injected Cy3-conjugated microspheres and FITC-conjugated lectin into the circulatory system of animals under terminal anesthesia. Microsphere extravasation was reduced by 50 % in airways transplanted into VHL-haplodeficient recipients at day 28 posttransplantation (Fig. 4a, b). Coverage of ECs by pericytes stabilizes vessels, and decreases plasma extravasation, resulting in improved perfusion [26]. Double staining with the EC marker CD31 and the mural cell (i.e., pericyte) marker desmin revealed more desmin-expressing cells covering vessels in grafts transplanted into VHL-haplodeficient recipients (Fig. 4c). Further pericyte coverage quantification showed about 30 % increase in grafts from VHL-haplodeficient recipients (Fig. 4d). These structural studies indicate that VHL haplodeficiency enhanced airway vascular perfusion and alleviated tissue hypoxia in close association with improved vascular integrity.

Fig. 4
Improved vessel function and maturation in airways transplanted into recipients with Tie2+ cell VHL haplodeficiency. a Representative confocal images showing extravasated 50 nm microsphere (red) and microvascular perfusion (green) in normal airways ...

Diminished airway microvascular regeneration and perfusion in Tie2+ cell HIF-1α knockout recipients

To more specifically determine whether vascular regeneration of the tracheas was HIF-1α dependent, mice bearing HIF-1α knockout Tie2 lineage cells (Tie2Cre(+)HIF1α(fl/fl)) and Tie2Cre(−)HIF1α(fl/fl) controls were used as allograft recipients. Airway graft perfusion in HIF-1α knockout in Tie2Cre(+)HIF1α(fl/fl) recipient cells was decreased by ~50 % at both day 16 and day 21 (Fig. 5a, b). Examination of grafts by LDF confirmed decreased perfusion in tracheas transplanted into HIF-1α-deficient recipients (Fig. 5c). These data suggest that HIF-1α expression in Tie2 lineage cells is required for effective repair of airway microvasculature following allorejection-induced damage.

Fig. 5
Diminished microvascular perfusion of airways transplanted into recipient with HIF-1α knockout in Tie2 lineage cells. a Representative FITC-lectin microvascular perfusion images at various time points posttransplantation. b Quantification of relative ...

Tie2+ cell VHL haplodeficiency attenuates allograft invasion by A. fumigatus

To evaluate the translational impact of VHL haplodeficiency-associated increased tissue perfusion, we compared Tie2Cre(−)VHL(fl/+) and Tie2Cre(+)VHL(fl/+) mice, using a standard Aspergillus tracheal infection assay. Mice were infected at day 16 posttransplantation and evaluated at day 18 for histopathological differences using GMS stain to detect fungi. Fungal burden and depth of invasion were graded on a semiquantitative scale (Supplementary Fig. 3a, fungal burden (0–4 scale), and Supplementary Fig. 3b, depth of fungal invasion (0–3 scale)). Allografts were evaluated with longitudinal or transverse sections (5-μm thickness) through the entire depth of the tracheal sample. On average, 420 transverse sections or 180 longitudinal sections were evaluated per tracheal sample. For each allograft, the section with the highest fungal burden or depth of invasion was used for scoring. Fungal burden was similar between Tie2Cre(+)VHL(fl/+) and Tie2Cre(−)VHL(fl/+) mice (mean fungal burden score, 2.8 and 3.2, respectively, P = 0.5) (Fig. 6a). In contrast, the degree of A. fumigatus invasion was significantly lower in VHL-haplodeficient recipients compared to control mice (mean depth of fungal invasion score, 0.3 and 1.9, respectively, P = 0.04) (Fig, 6b). In 83 % (5/6) of the VHL-haplodeficient mice, A. fumigatus was noninvasive (depth of fungal invasion grade 0) (Fig. 6c), whereas in the control mice, 75 % (6/8) showed a grade 2 (to subepithelial layer) or greater depth of invasion (Fig. 6d, e).

Fig. 6
Tie2+ cell VHL haplodeficiency attenuates A. fumigatus invasion. All animals were infected with A. fumigatus on posttransplant day 16 and euthanized on day 18. A semiquantitative scoring system was used to grade the degree of fungal burden (0–4 ...

Discussion

We previously showed that recipient-derived Tie2+ cells are essential in the repair of damaged airway microvasculature following transplantation [10]. In the current study, we demonstrated that airway microvascular regeneration is promoted by VHL knockdown in Tie2 lineage cells. Microvascular perfusion is significantly prolonged in tracheas transplanted into recipients that are VHL-haplodeficient in Tie2 lineage cells. Although we cannot rule out the effect of VHL-haplodeficient hematopoietic cells, expression of common immune response- and inflammation-induced cytokines was not significantly altered in VHL-haplodeficient recipients, suggesting that extended microvascular perfusion likely resulted from accelerated vascular repair and not from diminished alloimmune response-induced vascular damage. To examine whether improved vascular regeneration was associated with enhanced reparative ability of recipient-derived ECs, we demonstrated that VHL-haplodeficient lung ECs exhibited enhanced migration, increased capability of cord formation, and resistance to serum starvation-induced cell death, suggesting that these cells may have a survival advantage in the hypoxic microenvironment of the rejecting airway. Therefore, VHL haplodeficiency may increase airway microvascular repair by enhancing the angiogenic activity of ECs. It is not known whether VHL expression levels affect the function of TEMs, but as a subgroup of BMDACs, VHL haplodeficiency could conceivably reprogram TEM metabolism and augment their survival in an ischemic environment, as has been suggested [15].

Production of angiogenic factors in an ischemic microenvironment is associated with microvascular regeneration. We observed an increased expression of the angiogenic factor, SDF-1, in airways transplanted into recipients with VHL haplodeficiency. SDF-1 is a HIF-1 target gene product that is essential for the recruitment of CXCR4-expressing proangiogenic cells [10, 27]. Although CXCR4 and VEGFR2 expressions were not significantly different in airways transplanted into control and VHL-haplodeficient recipients, Tie2 expression was ~2-fold higher in airways transplanted into VHL-haplodeficient recipients. These data suggest that VHL haplodeficiency increases the expression of angiogenic factors, promoting recruitment and retention of angiogenic cells, and thus may establish a positive feedback loop to promote vascular repair.

In tracheas transplanted into VHL-haplodeficient recipients, we also showed a significant increase in ANGPT1 expression. ANGPT1 prevents the formation of the intercellular gaps in the endothelium, stabilizing the vasculature and protecting against leakage [2830]. Although not required in quiescent mature vasculature, ANGPT1 functions as a protective factor, regulating responses to tissue injury and microvascular disease in diabetes [31]. In contrast, expression of ANGPT2 weakens endothelial–pericyte interactions, resulting in pericyte loss and vascular instability [32, 33]. It was recently shown that in conditions characterized by sustained inflammation, pericyte investment of the endothelium was required for the anti-leak actions of ANGPT1 [18]. Congruent with our findings for ANGPT1 in VHL-haplodeficient recipients, we also showed that regenerated vessels are less leaky and have more pericyte coverage. Together our data suggest that VHL haplodeficiency may increase vascular stability by regulating the expression levels of ANGPT1 and downstream signaling pathways, which stabilizes the vasculature through augmentation of mural cell coverage.

In recipients with HIF-1α knockout in Tie2 lineage cells, we demonstrated that microvascular repair is significantly diminished, suggesting that HIF-1α expressed in Tie2+ cells is essential for repair of damaged microvasculature following alloimmune rejection. This finding is consistent with the previously established concepts that: (a) HIF-1 plays an essential role in vascular remodeling [34]; (b) EC HIF-1α deficiency decreases cardiac capillary density following pressure overload [35]; and (c) HIF-1 deficiency impairs burn wound vascularization and homing of BMDACs [36]. We cannot rule out the possibility that EC-expressed HIF-2α also may have contributed to airway microvascular repair and regeneration associated with VHL haplodeficiency. In fact, EC HIF-2α has been associated with increased vascular stability in tumor xenograft microvasculature [16] and plays an important role in revascularization in limb ischemia and autochthonous skin tumor models [37]. Nevertheless, from our results, it is clear that loss of HIF-1α alone in recipient Tie2+ cells was sufficient to significantly increase the duration of ischemia associated with allograft rejection.

Finally, we demonstrate that VHL haplodeficiency decreased the depth of A. fumigatus graft invasion when compared with infected WT controls, suggesting another therapeutic role for modulating HIF in lung transplant recipients. Although A. fumigatus is a facultative aerobe, it has the capacity to thrive in hypoxic conditions, an adaptation that may be critical for the mold’s pathogenicity [3841]. As A. fumigatus naturally grows in decaying organic matter, it is not surprising that improving microvascular perfusion and tissue health may lessen the invasive nature of the pathogen. Alternatively, increased expression of HIF-1α may itself play a role in decreasing A. fumigatus invasion. Although the role of HIF in fungal pathogenesis is not well described, HIF plays a key role in mitigating bacterial pathogenesis [42, 43]. For instance, the downregulation of HIF-1α by Chlamydia is thought to provide a virulence advantage for the organism [43]. Another possibility is that VHL-haplodeficient and control recipients differed in their immune response to the fungus. However, as the two demonstrated baseline similarity in their expression of immune and inflammation-induced cytokines (Supplementary Fig. 2), differences in the immune response are not likely to account for the observed differences in fungal virulence. It is also notable that the degree of fungal burden was similar in VHL haplodeficient and WT control mice (Fig. 6a). Thus, the observed effect was likely a result of mitigating the pathogen’s interaction with the host rather than lowering fungal burden, as might be observed with the use of antifungal agents.

In summary, we showed that the increased expression of HIF-1α in recipient Tie2 lineage cells through VHL knockdown promotes microvascular repair of tracheal allografts, which in turn leads to enhanced perfusion. VHL knockdown promotes vascular repair through several mechanisms, which include: enhancing the activity of angiogenic cells, as well as their recruitment, retention, and survival; increasing the expression of angiogenic growth factors; and stabilizing regenerated vessels. Moreover, we demonstrate the translational relevance of the current work by focusing on two factors associated with chronic rejection: ischemia and infection. Higher expression of HIF-1α in the transplant recipient promotes microvessel integrity and may play an important role in modulating the host–pathogen interaction for A. fumigatus, a common pathogen and major clinical risk factor for the development of OB in lung transplant recipients [44, 45]. This work complements our prior study [10] showing that enhanced HIF-1α in donor tissue also facilitates vascular healing, suggesting that treatment of both graft and recipient with drug or gene therapy to induce HIF-1 might be clinically beneficial. The actions of HIF-1α are pleiotropic, and its actions contribute to both the promotion and resolution of inflammation in biological processes [46]. Additionally, HIF-1α appears to exert multiple protective functions on mucosal surfaces (e.g., regulating defensins [47]). Given that the aging process impedes normal angiogenic cell mobilization and can be restored through the enhancement of HIF-1 activity [48], augmenting HIF-1α activity may be particularly effective for preventing chronic rejection in elderly transplant recipients. In summary, this study suggests that targeting recipient-derived angiogenic cells may have value as a therapeutic approach for preventing chronic rejection through increasing airway microcirculation and modulating the pathogenicity of OB-inducing microorganisms.

Electronic supplementary material

ESM 1(3.6M, pdf)

(PDF 3,772 kb)

Acknowledgments

This study was supported by NIH grant HL095686 and by a Veterans Affairs Merit Award BX000509 to M.R. Nicolls.

Conflict of interest

The authors declare no conflict of interest.

Footnotes

X.J. and J.L.H. contributed equally to this manuscript.

References

1. Weigt SS, Wallace WD, Derhovanessian A, Saggar R, Lynch JP, Belperio JA. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment. Semin Respir Crit Care Med. 2010;31:189–207. doi: 10.1055/s-0030-1249116. [PubMed] [Cross Ref]
2. Luckraz H, Goddard M, McNeil K, Atkinson C, Charman SC, Stewart S, Wallwork J. Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 2004;23:527–531. doi: 10.1016/j.healun.2003.07.003. [PubMed] [Cross Ref]
3. Luckraz H, Goddard M, McNeil K, Atkinson C, Sharples LD, Wallwork J. Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? Ann Thorac Surg. 2006;82:1212–1218. doi: 10.1016/j.athoracsur.2006.03.070. [PubMed] [Cross Ref]
4. Weigt SS, Copeland CA, Derhovanessian A, Shino MY, Davis WA, Snyder LD, Gregson AL, Saggar R, Lynch JP, 3rd, Ross DJ, Ardehali A, Elashoff RM, Palmer SM, Belperio JA. Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study. Am J Transplant. 2013 [PMC free article] [PubMed]
5. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18:44–69. doi: 10.1128/CMR.18.1.44-69.2005. [PMC free article] [PubMed] [Cross Ref]
6. Sole A, Morant P, Salavert M, Peman J, Morales P. Aspergillus infections in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect. 2005;11:359–365. doi: 10.1111/j.1469-0691.2005.01128.x. [PubMed] [Cross Ref]
7. Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol. 2007;45:305–320. doi: 10.1080/13693780701200372. [PubMed] [Cross Ref]
8. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am. 2003;17:113–134. doi: 10.1016/S0891-5520(02)00067-3. [PubMed] [Cross Ref]
9. Babu AN, Murakawa T, Thurman JM, Miller EJ, Henson PM, Zamora MR, Voelkel NF, Nicolls MR. Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis. J Clin Invest. 2007;117:3774–3785. doi: 10.1172/JCI32311. [PMC free article] [PubMed] [Cross Ref]
10. Jiang X, Khan MA, Tian W, Beilke J, Natarajan R, Kosek J, Yoder MC, Semenza GL, Nicolls MR. Adenovirus-mediated HIF-1alpha gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest. 2011;121:2336–2349. doi: 10.1172/JCI46192. [PMC free article] [PubMed] [Cross Ref]
11. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399–408. doi: 10.1016/j.cell.2012.01.021. [PMC free article] [PubMed] [Cross Ref]
12. Bader HL, Hsu T. Systemic VHL gene functions and the VHL disease. FEBS Lett. 2012;586:1562–1569. doi: 10.1016/j.febslet.2012.04.032. [PMC free article] [PubMed] [Cross Ref]
13. Eckle T, Hartmann K, Bonney S, Reithel S, Mittelbronn M, Walker LA, Lowes BD, Han J, Borchers CH, Buttrick PM, Kominsky DJ, Colgan SP, Eltzschig HK. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med. 2012;18:774–782. doi: 10.1038/nm.2728. [PMC free article] [PubMed] [Cross Ref]
14. Rey S, Lee K, Wang CJ, Gupta K, Chen S, McMillan A, Bhise N, Levchenko A, Semenza GL. Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci U S A. 2009;106:20399–20404. doi: 10.1073/pnas.0911921106. [PubMed] [Cross Ref]
15. Rey S, Luo W, Shimoda LA, Semenza GL. Metabolic reprogramming by HIF-1 promotes the survival of bone marrow-derived angiogenic cells in ischemic tissue. Blood. 2011;117:4988–4998. doi: 10.1182/blood-2010-11-321190. [PubMed] [Cross Ref]
16. Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz de Almodovar C, De Smet F, Vinckier S, Aragones J, Debackere K, Luttun A, Wyns S, Jordan B, Pisacane A, Gallez B, Lampugnani MG, Dejana E, Simons M, Ratcliffe P, Maxwell P, Carmeliet P. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009;136:839–851. doi: 10.1016/j.cell.2009.01.020. [PMC free article] [PubMed] [Cross Ref]
17. Khan MA, Dhillon G, Jiang X, Lin YC, Nicolls MR. New methods for monitoring dynamic airway tissue oxygenation and perfusion in experimental and clinical transplantation. Am J Physiol Lung Cell Mol Physiol. 2012;303:L861–L869. doi: 10.1152/ajplung.00162.2012. [PubMed] [Cross Ref]
18. Fuxe J, Tabruyn S, Colton K, Zaid H, Adams A, Baluk P, Lashnits E, Morisada T, Le T, O'Brien S, Epstein DM, Koh GY, McDonald DM. Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation. Am J Pathol. 2011;178:2897–2909. doi: 10.1016/j.ajpath.2011.02.008. [PubMed] [Cross Ref]
19. Sato M, Keshavjee S. Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling. Semin Thorac Cardiovasc Surg. 2008;20:173–182. doi: 10.1053/j.semtcvs.2008.05.002. [PubMed] [Cross Ref]
20. Tang N, Mack F, Haase VH, Simon MC, Johnson RS. pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol. 2006;26:2519–2530. doi: 10.1128/MCB.26.7.2519-2530.2006. [PMC free article] [PubMed] [Cross Ref]
21. Champion KJ, Guinea M, Dammai V, Hsu T. Endothelial function of von Hippel-Lindau tumor suppressor gene: control of fibroblast growth factor receptor signaling. Cancer Res. 2008;68:4649–4657. doi: 10.1158/0008-5472.CAN-07-6003. [PMC free article] [PubMed] [Cross Ref]
22. Lange C, Heynen SR, Tanimoto N, Thiersch M, Le YZ, Meneau I, Seeliger MW, Samardzija M, Caprara C, Grimm C. Normoxic activation of hypoxia-inducible factors in photoreceptors provides transient protection against light-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2011;52:5872–5880. doi: 10.1167/iovs.11-7204. [PubMed] [Cross Ref]
23. Carroll VA, Ashcroft M. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res. 2006;66:6264–6270. doi: 10.1158/0008-5472.CAN-05-2519. [PubMed] [Cross Ref]
24. Lasater EA, Li F, Bessler WK, Estes ML, Vemula S, Hingtgen CM, Dinauer MC, Kapur R, Conway SJ, Ingram DA., Jr Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans. J Clin Invest. 2010;120:859–870. doi: 10.1172/JCI41443. [PMC free article] [PubMed] [Cross Ref]
25. Khan MA, Jiang X, Dhillon G, Beilke J, Holers VM, Atkinson C, Tomlinson S, Nicolls MR. CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants. Circ Res. 2011;109:1290–1301. doi: 10.1161/CIRCRESAHA.111.250167. [PMC free article] [PubMed] [Cross Ref]
26. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58–62. doi: 10.1126/science.1104819. [PubMed] [Cross Ref]
27. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858–864. doi: 10.1038/nm1075. [PubMed] [Cross Ref]
28. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286:2511–2514. doi: 10.1126/science.286.5449.2511. [PubMed] [Cross Ref]
29. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000;6:460–463. doi: 10.1038/74725. [PubMed] [Cross Ref]
30. Baffert F, Le T, Thurston G, McDonald DM. Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol. 2006;290:H107–H118. doi: 10.1152/ajpheart.00542.2005. [PubMed] [Cross Ref]
31. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest. 2011;121:2278–2289. doi: 10.1172/JCI46322. [PMC free article] [PubMed] [Cross Ref]
32. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277:55–60. doi: 10.1126/science.277.5322.55. [PubMed] [Cross Ref]
33. Pfister F, Wang Y, Schreiter K, vom Hagen F, Altvater K, Hoffmann S, Deutsch U, Hammes HP, Feng Y. Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol. 2010;47:59–64. doi: 10.1007/s00592-009-0099-2. [PubMed] [Cross Ref]
34. Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res. 2010;86:236–242. doi: 10.1093/cvr/cvq045. [PMC free article] [PubMed] [Cross Ref]
35. Wei H, Bedja D, Koitabashi N, Xing D, Chen J, Fox-Talbot K, Rouf R, Chen S, Steenbergen C, Harmon JW, Dietz HC, Gabrielson KL, Kass DA, Semenza GL. Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-beta signaling. Proc Natl Acad Sci U S A. 2012;109:E841–E850. doi: 10.1073/pnas.1202081109. [PubMed] [Cross Ref]
36. Sarkar K, Rey S, Zhang X, Sebastian R, Marti GP, Fox-Talbot K, Cardona AV, Du J, Tan YS, Liu L, Lay F, Gonzalez FJ, Harmon JW, Semenza GL. Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells. Cardiovasc Res. 2012;93:162–169. doi: 10.1093/cvr/cvr282. [PMC free article] [PubMed] [Cross Ref]
37. Skuli N, Majmundar AJ, Krock BL, Mesquita RC, Mathew LK, Quinn ZL, Runge A, Liu L, Kim MN, Liang J, Schenkel S, Yodh AG, Keith B, Simon MC. Endothelial HIF-2alpha regulates murine pathological angiogenesis and revascularization processes. J Clin Invest. 2012;122:1427–1443. doi: 10.1172/JCI57322. [PMC free article] [PubMed] [Cross Ref]
38. Grahl N, Dinamarco TM, Willger SD, Goldman GH, Cramer RA. Aspergillus fumigatus mitochondrial electron transport chain mediates oxidative stress homeostasis, hypoxia responses and fungal pathogenesis. Mol Microbiol. 2012;84:383–399. doi: 10.1111/j.1365-2958.2012.08034.x. [PMC free article] [PubMed] [Cross Ref]
39. Grahl N, Puttikamonkul S, Macdonald JM, Gamcsik MP, Ngo LY, Hohl TM, Cramer RA. In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary Aspergillosis. PLoS Pathog. 2011;7:e1002145. doi: 10.1371/journal.ppat.1002145. [PMC free article] [PubMed] [Cross Ref]
40. Grahl N, Shepardson KM, Chung D, Cramer RA. Hypoxia and fungal pathogenesis: to air or not to air? Eukaryot Cell. 2012;11:560–570. doi: 10.1128/EC.00031-12. [PMC free article] [PubMed] [Cross Ref]
41. Hall LA, Denning DW. Oxygen requirements of Aspergillus species. J Med Microbiol. 1994;41:311–315. doi: 10.1099/00222615-41-5-311. [PubMed] [Cross Ref]
42. Kontoyiannis DP. Manipulation of host angioneogenesis: a critical link for understanding the pathogenesis of invasive mold infections? Virulence. 2010;1:192–196. doi: 10.4161/viru.1.3.11380. [PMC free article] [PubMed] [Cross Ref]
43. Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol. 2009;9:609–617. doi: 10.1038/nri2607. [PubMed] [Cross Ref]
44. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med. 2001;164:S39–S45. doi: 10.1164/ajrccm.164.supplement_2.2106065. [PubMed] [Cross Ref]
45. Zanini A, Chetta A, Imperatori AS, Spanevello A, Olivieri D. The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. Respir Res. 2010;11:132. doi: 10.1186/1465-9921-11-132. [PMC free article] [PubMed] [Cross Ref]
46. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364:656–665. doi: 10.1056/NEJMra0910283. [PMC free article] [PubMed] [Cross Ref]
47. Kelly CJ, Glover LE, Campbell EL, Kominsky DJ, Ehrentraut SF, Bowers BE, Bayless AJ, Saeedi BJ, Colgan SP. Fundamental role for HIF-1alpha in constitutive expression of human beta defensin-1. Mucosal Immunol. 2013 [PMC free article] [PubMed]
48. Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, Liu YV, Zhang H, Strazza M, Rey S, Savino L, Zhou YF, McDonald KR, Na Y, Vandiver S, Rabi A, Shaked Y, Kerbel R, Lavallee T, Semenza GL. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res. 2007;101:1310–1318. doi: 10.1161/CIRCRESAHA.107.153346. [PubMed] [Cross Ref]

Articles from Springer Open Choice are provided here courtesy of Springer